DrugPatentWatch Database Preview
« Back to Dashboard
Summary for Patent: 4,938,763
|Title:||Biodegradable in-situ forming implants and methods of producing the same|
|Abstract:||A biodegradable polymer is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. A thermoplastic system to form said implant comprises the steps of dissolving a non-reactive polymer in biocompatible solvent to form a liquid, placing the liquid within the animal, and allowing the solvent to dissipate to produce the implant. An alternative, thermosetting system comprises mixing together effective amounts of a liquid acrylic ester terminated, biodegradable prepolymer and a curing agent, placing the liquid mixture within an animal and allowing the prepolymer to cure to form the implant. Both systems provide a syringeable, solid biodegradable delivery system by the addition of an effective level of biologically active agent to the liquid before injection into the body.|
|Inventor(s):||Dunn; Richard L. (Fort Collins, CO), English; James P. (Birmingham, AL), Cowsar; Donald R. (Birmingham, AL), Vanderbilt; David P. (Birmingham, AL)|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for patent 4,938,763|
1. A method of forming an implant in-situ, in a living body, comprising the steps of:
(a) dissolving a non-reactive, water-insoluble polymer in a biocompatible, water-soluble solvent to form a liquid;
(b) placing said liquid within said body; and
(c) allowing said solvent to dissipate to produce a solid implant.
2. The method of claim 1, wherein said solvent is comprised of a binary solvent mixture having a first solvent capable of dissolving said polymer and a second solvent incapable of dissolving said polymer, said first and second solvents being present in said mixture at a ratio ouch that said polymer is soluble therein, so that said polymer is precipitated from said liquid upon the placing of said liquid within said animal, thereby resulting in an increase in said ratio of said second solvent to said first solvent.
3. The method of claim 1, and further comprising delivering said liquid in-situ through a needle.
4. The method of claim 3, wherein said polymer is a lactide polymer and said second solvent is selected from the group consisting of water, ethanol and propylene glycol.
5. The method of claim 1, and further comprising the step of adding an effective amount of biologically active agent to said liquid to provide an implant which releases said agent by diffusion, erosion or a combination of diffusion and erosion as said plant biodegrades.
6. The method of claim 5, wherein said implant is formed in a periodontal pocket in said body.
7. The method of claim 6, wherein said biologically-active agent is selected from the group consisting of benzophenanthridine alkaloid and tetracycline.
8. The method of claim 5, wherein said biologically-active agent comprises a benzophenanthridine alkaloid.
9. The method of claim 8, wherein said alkaloid comprises sanguinarine chloride.
10. The method of claim 8, wherein said alkaloid comprises ethoxydihydrosanguinarine.
11. The method of claim 5, wherein said biologically-active agent comprises tetracycline base.
12. The method of claim 5, wherein said biologically-active agent comprises tetracycline hydrochloride.
13. A biodegradable drug delivery implant for a body produced according to the method of claim 5.
14. The method of claim 1, wherein said polymer is biodegradable.
15. The method of claim 1, wherein said polymer is selected from the group consisting of polylactides, polyglycolides, polycaprolactones, polydioxanones, polycarbonates, polyhydroxybutyrates, polyalkylene oxalates, polyanhydrides, polyamides, polyesteramides, polyurethanes, polyacetals, polyketals, polyorthocarbonates, polyphosphazenes, polyhydroxyvalerates, polyalkylene succinates, poly(malic acid), poly(amino acids), chitin, chitosan, and polyorthoesters, and copolymers, terpolymers and combinations and mixtures thereof.
16. The method of claim 1, wherein said polymer is selected from the group consisting of polylactides, polycaprolactones and copolymers thereof with glycolide.
17. The method of claim 1, wherein said solvent is selected from the group consisting of N-methyl-2-pyrrolidone, 2-pyrrolidone, ethanol, propylene glycol, acetone, ethyl acetate, methyl acetate, methyl ethyl ketone, dimethylformamide, dimethyl sulfoxide, tetrahydrofuran, caprolactam, decylmethylsulfoxide, oleic acid and 1-dodecylazacycloheptan-2-one and combinations and mixtures thereof.
18. The method of claim 1, wherein said solvent is selected from the group consisting of N-methyl-2-pyrrolidone, 2-pyrrolidone, dimethyl sulfoxide and acetone, and a combination or mixture thereof.
19. A biodegradable implant for a body produced according to the method of claim 1.
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.